Australia markets closed

Provectus Biopharmaceuticals, Inc. (PVCT)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.1930+0.0017 (+0.91%)
At close: 03:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
1,749
1,749
2,389
2,608
2,813
Selling general and administrative
1,732
1,732
2,025
2,055
2,145
Total operating expenses
2,910
2,910
3,391
4,636
4,932
Operating income or loss
-2,910
-2,910
-3,391
-4,636
-4,932
Interest expense
216.214
216.214
163.691
961.698
1,748
Total other income/expenses net
24.227
24.227
0.433
58.174
-1.273
Income before tax
-3,102
-3,102
-3,555
-5,540
-6,678
Income from continuing operations
-3,102
-3,102
-3,555
-5,540
-6,678
Net income
-3,102
-3,102
-3,555
-5,540
-6,678
Net income available to common shareholders
-3,102
-3,102
-3,555
-5,540
-6,678
Basic EPS
-0.01
-
-0.01
-0.01
-0.02
Diluted EPS
-0.01
-
-0.01
-0.01
-0.02
Basic average shares
419,502
-
419,470
408,223
393,252
Diluted average shares
419,502
-
419,470
408,223
393,252